Read all vaccine information available from your health care professional before receiving the vaccine. If you have any questions, ask your health care professional. This vaccine is injected into ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the ...

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.

The pneumococcal vaccine can protect you from an infection caused by the bacteria Streptococcus pneumoniae or pneumococcus. (Photo Credit: Bernard Chantal/Dreamstime) Pneumococcal disease can ...

Merck MRK announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of its 21-valent pneumococcal conjugate vaccine ...

Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine, a ...

According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of ...

In addition to increasing vaccine coverage in older adults, they need to monitor the changing epidemiology of pneumococcal serotypes causing invasive disease. [134] In the face of these changes ...

Merck, known as MSD outside of the United States and Canada, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of ...

Vaccination with CAPVAXIVE may not protect all vaccine recipients. In the U.S., CAPVAXIVE is Merck’s FDA approved 21-valent pneumococcal conjugate vaccine indicated for active immunization for ...